{"filings":[{"id":442567,"accession_number":"0001193125-26-223985","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2026-05-14T20:06:06+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Q1 net loss $4.4M ($2.11/share); Zola volumes +18% YoY","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Net loss attributable to common stockholders $4.385M (EPS -$2.11) vs net income $2.599M ($1.90 EPS) in Q1 2025.","Zola coconut water unit volume +18% YoY; total revenue $1.1M down 8% due to $193k revenue reserve release in prior year.","SG&A $1.179M, lowest in public company history, down $559k YoY; cash and equivalents $0.954M vs $0.259M at year-end.","January 2026 warrant inducement generated $2.1M gross proceeds but caused $2.877M loss; company continues evaluating strategic alternatives.","Company plans new product launch fall 2026; Zola benefited from price increase at start of year."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.11,"consensus_revenue_estimate":null,"consensus_revenue_actual":1100000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":93021,"accession_number":"0001193125-26-142030","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2026-04-03T23:59:59+00:00","items":["4.01","9.01"],"status":"ready","headline":"Arcadia Biosciences dismisses Deloitte, hires RJI as new auditor; cites material weaknesses","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Dismissed Deloitte & Touche on March 30, 2026; engaged Ramirez Jimenez International CPAs (RJI) same day.","Deloitte's reports for 2024-2025 included going concern doubt due to accumulated deficit and recurring net losses.","No disagreements with Deloitte, but material weaknesses in internal controls (segregation of duties, IT controls) existed as of Dec 31, 2025.","RJI will handle Q1 2026 review and FY 2026 audit; no prior consultations with RJI on accounting matters."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104304,"accession_number":"0001193125-26-126220","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2026-03-26T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Biosciences reports FY2025 net loss of $2.3M; Zola revenues up 17% YoY; business combination terminated","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2025 revenue $901K (-26% YoY); full-year revenue $4.86M (-4%). Net loss per share $1.71 vs $5.17 in 2024.","Zola coconut water sales rose 17% to $701K in 2025; SG&A reduced 27% YoY.","Roosevelt Resources terminated proposed business combination; Arcadia exercises preferred options for $2.1M gross proceeds.","Cash and short-term investments totaled $4.56M at Dec 31, 2025, down from $4.24M cash alone a year earlier.","Net cash used in operations improved 49% to $4.74M in 2025."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104303,"accession_number":"0001193125-26-041144","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2026-02-06T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Arcadia Biosciences directors Bolles and Carosella resign effective Feb 4","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Albert D. Bolles, Ph.D. (Compensation Committee) and Deborah Carosella (Compensation, Nominating/Governance) resigned as directors.","Resignations effective February 4, 2026; both agreed to remain available as advisors.","Company states resignations are not the result of any disagreement with the Board or operations.","No replacement directors announced; board size reduced from at least 5 to 3 members."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":104302,"accession_number":"0001193125-26-012028","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2026-01-14T23:59:59+00:00","items":["1.01","3.02","3.03","7.01","9.01"],"status":"ready","headline":"Arcadia Biosciences raises $2.1M via exercise of options at reduced price; issues new options","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Gross proceeds of approx. $2.1M from exercise of 808,595 existing options at reduced price of $2.575/share.","Issued new unregistered options to purchase up to 1,617,190 shares at $2.325/share, expiring 30 months after resale registration effective date.","Existing options originally exercisable at $9.00/share; induced exercise by lowering price to $2.575.","Company to file resale registration statement for new option shares within 30 days of closing.","Net proceeds to be used for working capital and general corporate purposes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120598,"accession_number":"0001193125-25-335410","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-12-29T23:59:59+00:00","items":["1.02","7.01","9.01"],"status":"ready","headline":"Arcadia Biosciences (RKDA) merger with Roosevelt Resources terminated; no breakup fee","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Received termination notice on Dec 24, 2025; Closing did not occur by Aug 15, 2025.","No breakup fee payable by either party.","CEO says Arcadia will resume evaluating strategic alternatives for shareholder value.","Arcadia holds ~2.7M shares of Above Food Ingredients stock and potential additional consideration from GoodWheat sale.","Company highlights Nasdaq listing and Zola coconut water brand as assets for potential merger/transaction."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120597,"accession_number":"0001193125-25-331009","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-12-23T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Arcadia Biosciences annual meeting: say-on-pay passes narrowly; directors elected with ~55% support","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Approximately 51% of outstanding shares (703,677) were present at Dec 19, 2025 annual meeting.","Directors Bolles, Comcowich, Schaefer elected with ~79,500 FOR vs ~64,300 WITHHELD (55% of votes cast).","Advisory 'say-on-pay' vote passed 72,445 FOR vs 70,865 AGAINST, a margin of only 1,580 votes.","Ratification of Deloitte & Touche as auditor approved with 697,730 FOR, 4,574 AGAINST, 1,372 ABSTAIN."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.15,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120596,"accession_number":"0001193125-25-272368","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-11-07T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Q3 net income $856k vs loss $1.6M YoY; Zola YTD revenue up 26%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q3 total revenue $1.30M, down 15% YoY; loss from operations $1.15M.","Net income attributable to common $856k ($0.63 diluted EPS) vs loss $1.61M ($1.18 loss) in Q3 2024.","Zola coconut water YTD revenue up 26% YoY; gross margin >30% for 11th straight quarter.","Cash balance $1.12M at Sept 30, 2025; pending Roosevelt Resources combination delayed by federal shutdown.","Recognized $4.7M credit loss on Above Food note; holds 2.7M ABVE shares valued at $3.07M."],"consensus_eps_estimate":null,"consensus_eps_actual":-0.73,"consensus_revenue_estimate":null,"consensus_revenue_actual":3957000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":120595,"accession_number":"0001193125-25-249854","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-10-24T23:59:59+00:00","items":["5.08","8.01","9.01"],"status":"ready","headline":"Arcadia sets 2025 annual meeting for Dec 19; proposal deadline Nov 3","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Annual meeting scheduled for December 19, 2025; change of more than 30 days from 2024 meeting.","Stockholder proposals and director nominations must be received by November 3, 2025.","Previously announced exchange transaction with Roosevelt Resources, LP is separate from annual meeting."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137197,"accession_number":"0000950170-25-112267","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-08-29T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Arcadia CFO Mark Kawakami resigns; CEO Schaefer adds interim CFO role","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CFO Mark Kawakami resigns effective September 12, 2025; not due to any disagreement with the Company or auditors.","CEO Thomas J. Schaefer appointed interim CFO and principal accounting officer, effective upon Kawakami's resignation.","Schaefer previously served as CFO from January 2023 to July 2024; no compensation change for the additional role.","Schaefer will be available as an advisor after his departure; transition proceeds smoothly."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":137196,"accession_number":"0000950170-25-108983","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-08-14T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Q2 net loss $4.5M on $4.5M credit loss; Zola revenue up 24%","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenue $1.455M (+11% YoY); Zola coconut water sales grew 24% to $1.455M.","Net loss attributable to common $4.458M ($3.26/share) vs net income $1.061M ($0.78/share) in Q2 2024.","Recorded $4.5M credit loss on Above Food note receivable; received 2.7M shares of ABVE stock.","Eliminated $1M contingent liability via Bioseed India license termination; total YTD eliminated $2M.","Gross margins exceeded 30% for tenth consecutive quarter; SG&A fell 21% to $2.123M."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.36,"consensus_revenue_estimate":null,"consensus_revenue_actual":2655000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154486,"accession_number":"0000950170-25-073711","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-05-16T23:59:59+00:00","items":["7.01","8.01","9.01"],"status":"ready","headline":"Arcadia Biosciences reports default on $2M note payment from Above Food Corp; buyer in receivership","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Above Food Corp failed to pay $2M principal plus ~$475k interest due May 14, 2025 on note from GoodWheat sale.","Arcadia delivered notice to require ~3.5M AFII shares as prepayment of final $2M installment; no shares delivered.","Above Food Corp is subject to Canadian receivership proceedings; Arcadia intends to enforce remedies.","First of three annual $2M installments defaulted; entire unpaid balance may be accelerated under note terms."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154485,"accession_number":"0000950170-25-066420","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-05-08T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Biosciences Q1 net income $2.6M; Zola sales up 90%; Roosevelt deal amended to 90/10 split","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q1 2025 net income $2.6M ($1.90/share) vs net loss of $2.4M ($1.78 loss) in Q1 2024.","Revenue $1.2M (+22% YoY) driven by Zola coconut water sales up 90% and distribution up 70%.","Sold patent portfolios for $750K, eliminating $1M in liabilities; operating expenses near 10-year low.","Amended Roosevelt merger: fixed equity split 90% to Roosevelt partners, 10% to Arcadia stockholders; expected close late summer.","Cash and cash equivalents $3.16M, down from $4.24M at Dec 31, 2024."],"consensus_eps_estimate":-0.9996,"consensus_eps_actual":1.9,"consensus_revenue_estimate":null,"consensus_revenue_actual":1200000.0,"consensus_period":"2025-Q1","consensus_source":"xbrl+finnhub","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154484,"accession_number":"0000950170-25-062913","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-05-02T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Arcadia Biosciences amends merger with Roosevelt: extends deadline, revises share formula","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Termination date extended from May 15, 2025 to August 15, 2025.","Exchange shares fixed at 90% of post-closing outstanding (floor of 80%); prior cash adjustments removed.","Eliminated definitions for Cash Amount, Surplus Amount, Deficit Amount, and Trading Price.","Closing condition amended to require tax-free exchange under Section 351(a) of the Code."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":154483,"accession_number":"0000950170-25-050406","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-04-03T23:59:59+00:00","items":["1.01","9.01"],"status":"ready","headline":"Arcadia Biosciences enters agreement to receive $750,000 and transfer certain patent assets","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["A third party agreed to pay Arcadia $750,000 as part of the agreement.","The third party transferred back to Arcadia all rights and materials related to certain intellectual property and traits previously licensed.","Arcadia transferred its reduced gluten and oxidative stability granted patents and pending applications to the third party.","The parties amended a prior agreement to eliminate any future product royalty obligations payable to Arcadia."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":173040,"accession_number":"0000950170-25-042647","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2025-03-20T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Biosciences Q4 revenue +56% YoY to $1.2M; net loss widens; Roosevelt deal on track","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 total revenues $1.216M (+56% YoY); FY2024 revenues $5.045M (+13% YoY).","Net loss attributable to common stockholders Q4 $4.064M ($2.98/share) vs $2.853M in Q4 2023.","Full-year net loss improved to $7.038M ($3.17/share) from $13.981M in 2023.","Zola coconut water revenue up 124% in Q4 and 46% for full year.","Pending merger with Roosevelt Resources; post-close owners get ~90% of shares, Arcadia holders ~10%."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190067,"accession_number":"0000950170-24-135447","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-12-11T23:59:59+00:00","items":["7.01","9.01"],"status":"ready","headline":"Arcadia Biosciences to merge with oil and gas partnership Roosevelt Resources in all-stock deal","summary_kind":"llm","event_type":"m_and_a","confidence":"medium","bullets":["Signed Securities Exchange Agreement on Dec 5, 2024 for all-stock business combination with Roosevelt Resources, a Texas oil & gas partnership.","Transaction requires approval of Arcadia stockholders and Roosevelt partners; closing subject to customary conditions.","Arcadia to file Form S-4 registration statement with proxy/prospectus for stockholder vote on the proposed combination.","Roosevelt Resources is a private oil and gas partnership; combined company will trade under Arcadia's Nasdaq ticker RKDA.","Live webcast held Dec 11, 2024 to discuss deal; investor presentation furnished as Exhibit 99.1."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190066,"accession_number":"0000950170-24-133817","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-12-06T23:59:59+00:00","items":["1.01","5.01","5.02","7.01","9.01"],"status":"ready","headline":"Arcadia Biosciences to combine with Roosevelt Resources in all-stock reverse merger; Roosevelt owners to get ~90%","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Arcadia to issue shares for all Roosevelt equity; current Arcadia shareholders will own ~10% of combined company.","Roosevelt's primary asset: 16,208-acre CCUS oil and gas project in Texas Permian Basin.","Combined company management: Elliott Roosevelt Jr. as CEO, Jimmy Hawkins as President, Jerrel Branson as CFO.","Name change to Roosevelt Resources, Inc.; closing expected Q1 2025, subject to shareholder and regulatory approvals.","Arcadia had conducted strategic review since July 2023; deal advised by Lake Street Capital and Roth Capital."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.85,"calibrated_materiality_score":0.85,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":190065,"accession_number":"0000950170-24-125393","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Biosciences Q3 revenue up 18% to $1.5M; net loss narrows to $1.6M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Total revenues $1.537M, +18% YoY; Zola coconut water revenue +55% YoY.","Zola retail distribution expanded 68% vs Q3 2023.","Net loss attributable to common stockholders $1.612M ($1.18/share) vs $2.567M ($1.89) in Q3 2023.","Operating expenses increased 22% to $3.297M due to higher revenues and severance costs.","Cash and cash equivalents $3.936M, down from $6.518M at Dec 31, 2023."],"consensus_eps_estimate":null,"consensus_eps_actual":-2.18,"consensus_revenue_estimate":null,"consensus_revenue_actual":3829000.0,"consensus_period":"2024-Q3","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206561,"accession_number":"0000950170-24-100065","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K/A","filed_at":"2024-08-23T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Arcadia Biosciences discloses CEO/CFO compensation: $260k/$212k salary, stock options at $2.71","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Thomas Schaefer base salary $260k/yr; 2024 target bonus 50% as CEO, 40% as CFO prorated.","CFO Mark Kawakami base salary $212,063/yr; 2024 target bonus 30% as CFO, 20% as VP Finance prorated.","Each granted options to buy 20,000 shares at $2.71, vesting over 4 years (25% one-year cliff, 36 monthly).","Schaefer and Kawakami receive 6-month severance (non-CIC) or 12-month plus full equity vest (CIC).","Agreements expire third anniversary of July 5, 2024; at-will employment confirmed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206565,"accession_number":"0000950170-24-096215","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-08-13T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Q2 2024 net income $1.1M; sells wheat IP to Corteva for $4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q2 revenue $1.306M (flat YoY); net income $1.061M ($0.78/diluted share) vs $823K ($0.61) in Q2 2023.","Sold Resistant Starch durum trait to Corteva for $4M cash; GoodWheat brand sold to Above Food for $4M over 3 years.","Zola coconut water sales up 42% YoY; new pineapple and lime flavors shipping in Q2.","Net loss H1 2024 $1.362M ($1.00/share) improved from $8.561M ($7.70) H1 2023, helped by Corteva gain.","CEO Stan Jacot departed; Thomas J. Schaefer (former CFO) appointed president and CEO."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.0,"consensus_revenue_estimate":null,"consensus_revenue_actual":2293000.0,"consensus_period":"2024-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206564,"accession_number":"0000950170-24-092432","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-08-07T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Arcadia appoints CEO Thomas Schaefer to board as Class I director, filling Jacot vacancy","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Thomas J. Schaefer, current president and CEO, appointed Class I director effective August 1, 2024.","Appointment fills board vacancy created by Stanley Jacot's resignation on July 2, 2024.","Schaefer has served as CEO since July 2022 and as CFO since January 2023; no compensation change disclosed."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206563,"accession_number":"0000950170-24-082092","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-07-08T23:59:59+00:00","items":["5.02","9.01"],"status":"ready","headline":"Arcadia CEO Stanley Jacot resigns; CFO Schaefer promoted to CEO, Kawakami named CFO","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["Stanley Jacot, Jr. resigned as president, CEO, and director on July 2, 2024; cash severance $288,077 + 12-month option acceleration + COBRA through Feb 2025.","CFO Thomas J. Schaefer appointed president and CEO effective July 5, 2024; he had been CFO since Jan 2023.","Mark Kawakami appointed CFO effective July 5, 2024; he was VP Finance since Jan 2023; base salary $212,063.","Separation Agreement includes general release of claims, confidentiality, and non-disparagement by Jacot."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":206562,"accession_number":"0000950170-24-079602","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-07-01T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"Arcadia Biosciences stockholders approve all four proposals at 2024 annual meeting","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Amy Yoder elected with 160,017 votes for; Lilian Shackelford Murray with 149,613 for; 501,220 broker non-votes.","Ratification of Deloitte & Touche as auditors for FY 2024: 666,133 for, 13,547 against, 2,913 abstain.","Amendment to 2015 Omnibus Equity Incentive Plan approved: 120,214 for, 60,507 against, 652 abstain, 501,220 broker non-votes.","Advisory vote on executive compensation approved: 153,487 for, 27,183 against, 703 abstain, 501,220 broker non-votes."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.15,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223739,"accession_number":"0000950170-24-062449","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-05-20T23:59:59+00:00","items":["1.01","2.01","9.01"],"status":"ready","headline":"Arcadia sells GoodWheat business; receives $6M promissory note, pays $2M cash at close","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Net consideration $4M: $6M promissory note (3-yr, prime rate) from Above Food; Arcadia paid $2M cash at closing.","Principal due $2M on each anniversary; Arcadia can elect to settle $2M for Above Food stock at 90% of 20-day VWAP.","Pro forma 2022 net loss improves from ($15.4M) to ($8.5M); 2023 net loss from ($14.0M) to ($6.1M).","Transaction closed May 14, 2024; security agreement grants Arcadia lien on purchased assets (excl. inventory)."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223738,"accession_number":"0000950170-24-061526","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-05-17T23:59:59+00:00","items":["1.01","2.01","9.01"],"status":"ready","headline":"Arcadia sells resistant starch durum wheat trait to Corteva unit for $4M cash","summary_kind":"llm","event_type":"m_and_a","confidence":"high","bullets":["Sold patent and related rights for resistant starch durum wheat trait to Pioneer Hi-Bred (Corteva) for $4M cash.","Trait was never recorded on balance sheet; proceeds represent pure gain.","Arcadia retains production license for GoodWheat brand pasta until Corteva's commercial launch in North America.","Transaction closed May 13, 2024; patents include U.S. 10,246,717 and 11,649,464."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":223737,"accession_number":"0000950170-24-056928","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-05-09T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Q1 2024 revenue up 2% YoY; net loss narrows to $2.4M from $9.4M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Product revenue $1.255M (+2% YoY); fifth consecutive quarter with >30% gross margin.","Loss from continuing ops improved 21% to $3.064M; lowest in 6 years.","Net loss $2.423M ($1.78/share) vs $9.384M ($10.86/share) in Q1 2023, helped by absence of PIPE valuation loss.","GoodWheat in 3,500+ stores; Zola added ~200 stores in Q1, set to ship to ~1,300 more in Q2.","Cash & short-term investments $8.5M; operating cash burn $3.21M in quarter."],"consensus_eps_estimate":null,"consensus_eps_actual":-1.78,"consensus_revenue_estimate":null,"consensus_revenue_actual":1255000.0,"consensus_period":"2024-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":243147,"accession_number":"0000950170-24-038153","cik":1469443,"company_name":"Arcadia Biosciences, Inc.","ticker":"RKDA","form_type":"8-K","filed_at":"2024-03-28T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Arcadia Q4 revenues up 57% to $1.2M; full-year net loss narrows to $14.0M","summary_kind":"llm","event_type":"earnings","confidence":"high","bullets":["Q4 2023 product revenue $1.17M (+57% YoY); full-year revenue $5.33M (-28% from $7.42M due to prior-year grain sales and license revenue).","Full-year net loss att. to common stockholders $13.98M ($11.30/share) vs $15.38M ($25.65/share) in 2022, improved by lower operating expenses.","Cash, equivalents, and short-term investments totaled $11.6M at Dec. 31, 2023, down from $20.6M a year earlier; operating cash burn $15.3M.","GoodWheat now in three categories (pasta, pancake/waffle mixes, mac & cheese) and >3,500 stores; Zola coconut water launched pineapple and lime flavors in Q1 2024.","Company initiated strategic review in mid-2023 with Lake Street Capital Markets to explore M&A, sale, or other transactions to maximize GoodWheat value."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":1851195.8918918916,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}